**3. Standard treatment according to MoHFW for different severities of COVID-19 infection**

MoHFW (Ministry of Health and Family Welfare) is a government ministry in India that is responsible for health policy [53]. It is also in charge of all governmentsponsored family planning programmes in India. As a member of the Council of Ministers, the Minister of Health and Family Welfare has cabinet rank.

The standard treatment given by MoHFW for different severities is given below. Drug treatment for patients with mild cases:


Drug Treatment for patients with moderate cases:

i.Antipyretic (Paracetamol) for fever and pain,

## ii.Anti- tussives for cough


Drug treatment for patients with severe cases:


To conclude, these are the drugs that are used in India for the treatment of mild, moderate and severe covid infection. For mild-moderate infection, Molnupiravir, Azithromycin, JAK-STAT Inhibitors and Favipiravir. For severe covid infections, drugs like Remdesivir, Paxlovid, Nitric Oxide, Selinexor and Dexamethasone. Common treatment includes Nutritional and Vitamin Supplements, Paracetamol and Zinc. Additionally,Nitazoxanide, Niclosamide, Rintatolimod, Bencentinib, Plitidepsin, VIR-2703, Emetine hydrochloride, AT-527, Trabedersen, Stannous protoporphyrin, Antroquinonol, Apilimod dimesylate, Brilacidin, Infliximab, Abatacept, Cenicriviroc, Interleukin-1 inhibitors, Interleukin-7 inhibitors are drugs under trial for the

*Inclusive Review on Existing Treatment and Management Modalities for COVID-19 DOI: http://dx.doi.org/10.5772/intechopen.106011*

treatment for COVID 19 infection. As per the latest data from WHO, the total confirmed cases since the pandemic started till May end 2022 are 43,147,530 and the total deaths accounts to 524,539 [54].
